Articles From: GulfMark Offshore Announces Quarterly Dividend on Common Stock to GW Pharmaceuticals to Present at the Leerink Rare Disease Roundtable 2014


HOUSTON, Sept.
Sign-up for GulfMark Offshore Announces Quarterly Dividend on Common Stock investment picks
HOUSTON, July 21, 2014 (GLOBE NEWSWIRE) -- GulfMark Offshore, Inc. (NYSE:GLF) today announced its results of operations for the three- and six-month periods ended June 30, 2014.
Sign-up for GulfMark Offshore Announces Second Quarter 2014 Operating Results investment picks
HOUSTON, Oct.
Sign-up for GulfMark Offshore Announces Third Quarter 2014 Operating Results investment picks
OKLAHOMA CITY, July 10, 2014 (GLOBE NEWSWIRE) -- Gulfport Energy Corporation (Nasdaq:GPOR) ("Gulfport") today announced that Aaron Gaydosik has been appointed by the Company's Board of Directors to serve as Chief Financial Officer.
Sign-up for Gulfport Energy Corporation Names Aaron Gaydosik Chief Financial Officer investment picks
OKLAHOMA CITY, Aug.
Sign-up for Gulfport Energy Corporation Prices $300 Million Tack On Offering of Senior Notes investment picks
OKLAHOMA CITY, July 30, 2014 (GLOBE NEWSWIRE) -- Gulfport Energy Corporation (Nasdaq:GPOR) ("Gulfport") today provides an update on its midstream activities in the Utica Shale of Eastern Ohio, announces second quarter 2014 production and schedules second quarter 2014 financial and operational results conference call.
Sign-up for Gulfport Energy Corporation Provides Midstream Update, Reports Second Quarter 2014 Production and Schedules Second Quarter 2014 Financial and Operational Results Conference Call investment picks
OKLAHOMA CITY, Aug.
Sign-up for Gulfport Energy Corporation Reports Second Quarter 2014 Results investment picks
2014/10/8
SAVANNAH, Ga.
Sign-up for Gulfstream G650ER Certified By Federal Aviation Administration investment picks
2014/10/14
All-New Gulfstream G500 And G600 Optimize Speed, Cabin Comfort And Efficiency, Introduce Industry-Leading Safety Technologies SAVANNAH, Ga.
Sign-up for Gulfstream Introduces New Aircraft Family investment picks
DoubleLine Capital's Jeffrey Gundlach told CNBC on Tuesday that the highly anticipated public offering of Chinese e-commerce company Alibaba Group Holding (BABA) was probably the top of the stock market for 2014.
Sign-up for Gundlach: Alibaba IPO may have been 2014's market top investment picks
2014/9/25
Gupta Technologies , a division of Daegis, Inc. and global provider of application development, database and migration software has been named by the Fujitsu Legacy Modernization Offering Center as the first recipient of their Monthly Supplier Award.
Sign-up for Gupta Technologies is selected as Partner of the Month by the Fujitsu Legacy Modernization Offering Center investment picks
2014/9/9
Gupta Technologies , a global provider of application development, database and migration software, announces their plans to attend and participate in CTIA 2014 Super Mobility Week, running from September 9-11 at the Las Vegas Sands Expo and Convention Center.
Sign-up for Gupta Technologies to Attend Super Mobility Week 2014 in Las Vegas investment picks
Gupta Technologies , a global provider of application development, database and migration software, today announced a successful deployment of a mobile application using TD Mobile by the Friends of Israel (FOI) organization.
Sign-up for Gupta Technologies’ TD Mobile Enables Non-profit Organization, Friends of Israel, Access to Critical Data from Mobile Devices While in the Field investment picks
ATCHISON, Kan., Aug.
Sign-up for Gus Griffin Named to MGP's Board of Directors investment picks
ATCHISON, Kan., July 24, 2014 (GLOBE NEWSWIRE) -- The Board of Directors of MGP Ingredients, Inc. (Nasdaq:MGPI) today announced the appointment of beverage alcohol industry executive Gus Griffin as president and CEO of the company effective July 28.
Sign-up for Gus Griffin, Accomplished Beverage Alcohol Industry Exec., Brings Extensive Leadership Experience to Role as New MGP President and CEO investment picks
2014/9/17
Direct Marketing Pioneer Supports Complex Continuity Programs for Multiple Brands with NetSuite's Order Management Solution SAN MATEO, Calif.
Sign-up for Guthy-Renker Selects NetSuite for Global Transformation of Order Management investment picks
2014/10/7
Food Network Star to Visit Fan Tailgates, Judge a Burger Battle at AT&T Stadium MIAMI , Oct.
Sign-up for Guy Fieri To Join Carnival Cruise Lines For Gameday Fun At The Dallas Cowboys' October 19 Game investment picks
Hexcel Corporation (NYSE:HXL)(BOURSE:HXL) today announced that Mr.
Sign-up for Guy Hachey Named to Hexcel Corporation’s Board of Directors investment picks
Guyana Goldfields Achieves Financial Close and First Drawdown of the US$185 Million Project Finance Facility Canada NewsWire TORONTO , Oct.
Sign-up for Guyana Goldfields Achieves Financial Close and First Drawdown of the US$185 Million Project Finance Facility investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0971593001&sourceType=1 VANCOUVER, BRITISH COLUMBIA --
Sign-up for GVIC Acquires Majority Interest in Evaluate Energy investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0966823001&sourceType=1 VANCOUVER, BRITISH COLUMBIA --
Sign-up for GVIC Announces Completion of Real Estate Transaction investment picks
2014/10/14
- Physician reports show signals of efficacy and safety consistent with previously disclosed data, as well as maintenance of clinical effect beyond 12 weeks and high retention rate - - Data to be presented at R&D Day today commencing at 10:00 a.m. ET, 15:00 BST - Highlights 12 patients with Dravet syndrome reported a median overall reduction in convulsive seizure frequency of 51%-72% across a range of time points and analyses 12 patients with drop seizures (the types of seizures considered by the FDA in assessing primary efficacy for Lennox-Gastaut Syndrome trials) at baseline reported a median overall reduction in drop seizure frequency of 52%-76% Data on 58 patients with a wide range of drug-resistant epilepsies treated with Epidiolex show a median overall reduction in total seizure frequency of 36%-51% Overall, 40-70% of patients obtained a greater than 50% reduction in seizure frequency with a notable proportion achieving
Sign-up for GW Pharmaceuticals Announces New Physician Reports of Epidiolex(R) Treatment Effect in Children and Young Adults With Treatment-Resistant Epilepsy investment picks
- Trial data show promising signals of efficacy in patients who completed course of treatment - LONDON, Oct.
Sign-up for GW Pharmaceuticals Announces Preliminary Topline Results of Phase 2a Ulcerative Colitis Trial investment picks
LONDON, Sept.
Sign-up for GW Pharmaceuticals Research and Development Day Details investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: GulfMark Offshore Announces Quarterly Dividend on Common Stock to GW Pharmaceuticals to Present at the Leerink Rare Disease Roundtable 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices